“third-rock-ventures” Archives

in
Entry Author Date Location
Eyeing $500M, Moderna Outlines Plans for Biotech’s Biggest IPO Ever 11/09/18 Boston
Catch CRISPR 2.0, RNA-Targeting Drugs & More At “Disruptors” on Oct. 17 09/26/18 Boston
Agenda Posted for Boston’s Life Science Disruptors on Oct. 17 09/10/18 Boston
Working with Patients and a Fresh $80M, Fulcrum Eyes a 2019 IPO 09/05/18 Boston
Beam, Celsius & Arrakis at Boston’s Life Science Disruptors Oct. 17 08/27/18 Boston
Creating Companies Before 35: Meet the Young Innovator Award Finalists 08/08/18 Boston
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future? 08/08/18 San Francisco
Pliant Picks Up $62M to Test Lung, Liver Fibrosis Drug in the Clinic 07/16/18 San Francisco
Decibel Hauls in $55M to Bring Multiple Hearing Drugs to the Clinic 06/19/18 Boston
Langer, Yancopoulos & Hockfield to Headline Xcelerate at Biotech Week Boston 06/07/18 Boston
Celsius Snags $65M to Harness Single-Cell Genomics for Drug Discovery 05/15/18 Boston
Moderna’s Billions: Will Building Big Before an IPO Pay Off? 05/09/18 Boston
With $59M, Casma and Ex-Constellation CEO Take Aim at Cellular Trash 05/03/18 Boston
Third Rock’s Cedilla Launches with $56M for Protein Stability Drugs 04/24/18 Boston
Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer 04/24/18 San Francisco
Rheos Medicines Launches, Backed by $60M for Immunometabolism R&D 03/22/18 Boston
Flagship Bags $618M, Its Largest Raise Ever, For a New Startup Crop 12/20/17 Boston
Spero, Allena Nab $152M As Bio IPOs, With Insider Help, Continue Roll 11/02/17 Boston
Ex-Cubist CEO Bonney Emerges at Kaleido, Flagship’s Latest Microbiome Startup 09/18/17 Boston
Seeking to Cash in For Investors Again, Rhythm Pharma Files For IPO 09/06/17 Boston
Constellation Reboots With Eye On Immuno-Oncology, Hires New CEO 05/25/17 Boston
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer 05/14/17 Boston
Magenta Nabs More Cash, Licenses Drug To Boost Transplant Pipeline 05/02/17 Boston
Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies 04/11/17 Boston
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Rhythm Raises $41M to Bankroll Late-Stage Push For Obesity Drug 02/16/17 Boston
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Page 1 of 16 next page »